Effect of antidepressant therapy on executive function after stroke

Area of Science:

• Neuroscience
• Clinical Neurology
• Psychiatry

Background:

• Executive dysfunction is a frequent and debilitating consequence of stroke.
• Current treatment options for post-stroke executive dysfunction are limited.

Purpose of the Study:

• To investigate the efficacy of antidepressant medication in improving executive function following a stroke.
• To assess the long-term effects of antidepressants on cognitive function post-stroke.

Main Methods:

• A double-blind, placebo-controlled trial involving 47 stroke patients within six months of their event.
• Patients received 12 weeks of antidepressant treatment or placebo.
• Executive function was assessed at the end of treatment and after a 2-year follow-up.

Main Results:

• No immediate significant difference in executive function was observed between groups post-treatment.
• However, after 21 months, the placebo group experienced executive function decline, while the antidepressant group showed significant improvement.
• This improvement was independent of depressive symptom reduction.

Conclusions:

• Antidepressant therapy promotes sustained enhancement of executive function in stroke survivors.
• This long-term benefit may stem from neuroplastic changes in prefrontal cortical networks, potentially mediated by monoaminergic pathways and neurotrophic factors.